Search Results 1361-1370 of 21179 for Informed consent

1. Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock (MINOS) - Mayo Clinic

   Unwilling or unable to obtain informed consent from the participant or substitute decision maker. Revascularization of coronary artery disease performed in ...

2. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) - Mayo Clinic

   Participant is willing to give written informed consent; Age ≥ 21 years. Exclusion Criteria: LVEF < 35%; History of unprotected left main stenosis >50% on ...

3. Emricasan, A Caspase Inhibitor, For Treatment Of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   Male or female subjects 18 years or older, able to provide written informed consent and able to understand and willing to comply with the requirements of the ...

4. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

   ... consent. Age 18 years or older at the time of informed consent. ECOG performance status of 0 or 1. Adequate bone marrow, renal, hepatic, pulmonary and ...

5. Rollover Study Of Cenicriviroc For The Treatment Of Liver Fibrosis In Participants With Nonalcoholic Steatohepatitis - Mayo Clinic

   Provided a signed written informed consent form. Females of child-bearing potential and males participating in the study must agree to use at least 2 ...

6. American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis - Mayo Clinic

   Ability to give informed consent. If the patient is unable to give informed consent as a result of death or physical incapacity, then informed assent from next ...

7. About cancer clinical trials

   Each clinical trial requires informed consent from the participant. This consent ensures that you understand key facts and potential risks about the research ...

8. A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma - Mayo Clinic

   Willing and able to give written informed consent and adhere to protocol requirements. 3. Patient has a history of multiple myeloma with relapsed and ...

9. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) - Mayo Clinic

   Provide written informed consent. Male or female ages 18 or older. Evidence of cancer of the colon or rectum that is metastatic to the liver. NOTE: patients ...

10. Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) - Mayo Clinic

    Male or female subjects, 18-75 years of age at time of Screening who provide written informed consent prior to initiation of any study procedure.